BPC-157: Dosage, Protocol, and Research Guide
Body Protection Compound derived from gastric juice protein with powerful healing and anti-inflammatory properties
Mechanism
Stable gastric pentadecapeptide that promotes angiogenesis through VEGF upregulation, increases growth factor expression (EGF, TGF-β), modulates nitric oxide system, and accelerates tendon/ligament fibroblast proliferation and migration.
Protocol at a glance
| Starting dose | 250mcg |
|---|---|
| Maintenance dose | 250-500mcg |
| Maximum dose | 500mcg |
| Frequency | 1-2 times daily (often divided doses) |
| Typical duration | 4-8 weeks |
| Route | Subcutaneous injection or oral |
| Injection site | Near injury site or abdomen |
| Timing | Can be taken any time, oral for GI conditions |
Side effects
- Minimal reported side effects
- Non-toxic
- Well-tolerated
Contraindications
- Pregnancy
- Active cancer (theoretical concern due to angiogenesis)
Protocol notes
- Stimulates new blood vessel growth (angiogenesis)
- Boosts fibroblast activity and collagen production
- Accelerates healing of wounds, ligaments, tendons, muscles
- Supports gastrointestinal health and ulcer treatment
- Shows potential for nerve regeneration
- Also available in oral capsule form for GI conditions
- Strong safety profile with minimal side effects
Frequently asked questions
Does BPC-157 need to be refrigerated?
Yes. Store reconstituted BPC-157 refrigerated and use within 30 days. Do not freeze after reconstitution.
What is BPC-157 used for in research?
Research has focused on tissue healing, wound recovery, ligament and tendon repair, gastrointestinal health, and nerve regeneration. For research purposes only — consult a physician.
What are the reported side effects of BPC-157?
Published research reports minimal side effects. It is generally described as non-toxic and well-tolerated in preclinical studies. Individual responses vary — consult a healthcare provider.
Is BPC-157 legal?
BPC-157 is not FDA-approved as a pharmaceutical drug and is available for research purposes only. Regulatory status varies by country. Consult a legal and medical professional in your jurisdiction.
How long until BPC-157 starts working?
In preclinical studies, subjects often showed measurable tissue response within 1–2 weeks. Real-world anecdotal reports vary widely — some users report benefit within days, others need 3–4 weeks. Track dose and response with a protocol tracker for objective data.
Can BPC-157 be stacked with TB-500?
BPC-157 + TB-500 is the most commonly reported recovery stack in community protocols. Typical reported split: BPC-157 250mcg twice daily SubQ, TB-500 2.5mg weekly IM. This is community practice, not medical advice.
Oral vs. injectable BPC-157?
Most peer-reviewed research used injectable BPC-157 (SubQ or IM). Oral forms exist but have less published evidence. Consult research references and a physician when choosing administration route.
More Healing & Recovery peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.